Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Gastrointestinal Stromal Tumors × cabozantinib × Clear all

Sponsor

Conditions

Prostatic Neoplasms 13 Carcinoma, Renal Cell 12 Neoplasm Metastasis 7 Neoplasms 6 Carcinoma, Hepatocellular 5 Thyroid Neoplasms 4 Melanoma 4 Carcinoma, Non-Small-Cell Lung 4 Carcinoma, Medullary 4 Breast Neoplasms 4 Brain Neoplasms 4 Pancreatic Neoplasms 3 Neuroendocrine Tumors 3 Thyroid Cancer, Papillary 2 Small Cell Lung Carcinoma 2 Recurrence 2 Pain 2 Multiple Myeloma 2 Lung Neoplasms 2 Kidney Neoplasms 2 Glioma 2 Glioblastoma 2 Carcinoma, Transitional Cell 2 Carcinoma 2 Astrocytoma 2 Adenoma, Islet Cell 2 Adenocarcinoma, Follicular 2 Adenocarcinoma 2 Uveal Melanoma 1 Urinary Bladder Neoplasms 1

Interventions

Sunitinib 14 Imatinib Mesylate 12 nilotinib 7 ripretinib 3 regorafenib 3 4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one 3 pexidartinib 2 pembrolizumab 2 avapritinib 2 Bevacizumab 2 trametinib 1 spartalizumab 1 romidepsin 1 ponatinib 1 pazopanib 1 palbociclib 1 olaratumab 1 guadecitabine 1 ferric carboxymaltose 1 epacadostat 1 dabrafenib 1 cediranib 1 Surveys and Questionnaires 1 Sorafenib 1 Observation 1 Iron-Dextran Complex 1 Indocyanine Green 1 Immunoglobulin G 1 HhAntag691 1 Fluorescein 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡